The size of the Clinical Nutrition Market in the Asia Pacific was worth USD 3.82 Billion in 2022 and is estimated to be growing at a CAGR of 7.17% to reach USD 5.39 billion by 2027. The Asia-pacific clinical nutritional market is mainly driven by increasing awareness of such products among ordinary people.
Vitamins, Amino acids, minerals, carbohydrates, and proteins are some of the essential nutrients required in the diet. In addition, various diseases such as diabetes, cancer, GI diseases, kidney and cardiovascular diseases can be treated or controlled using clinical nutritional products. These are available in liquids, powders, tablets, injections, or foods such as yogurt and Probiotics.
The high birth rate, growing geriatric population, the surge in the number of victims of malnutrition getting treatment, a high number of premature births, the rising prevalence of lifestyle-associated diseases, and the increasing incidence of cancer and central nervous system diseases are some of the key factors driving the clinical nutrition market in the Asia-pacific region. Additionally, factors such as the rising frequency of metabolic illnesses, high healthcare spending, and the expansion of the middle class in emerging nations are estimated to accelerate the growth rate of the clinical nutrition industry forward in the APAC region.
Dietary therapy is required for normal growth and development and to prevent acute and long-term impacts of the disorder. Failure to follow a specific nutritional plan can cause complications and even death in those with metabolic illnesses. Patients with genetic metabolic disorders will require nutritional therapy for the rest of their lives. Patients with a range of inborn metabolic disorders require a multidisciplinary approach involving nutritional and medicinal treatment. The bulk of metabolic illnesses are caused by the body’s inability to produce non-essential compounds such as vitamins, amino acids, and several substances involved in metabolic pathways. The majority of these problems can be resolved with just one or two vitamin supplements. The aforementioned factors are expected to contribute to the market’s growth during the forecast period.
However, the growth rate of the APAC clinical nutrition market is expected to be hampered by the lack of understanding about clinical medical nutrition and strict regulations during the forecast period. In addition, the diverse nature of government coverage/reimbursement between nations is one factor that could limit market expansion.
Impact of COVID-19 on the APAC clinical nutrition market:
The COVID-19 pandemic is likely to impact the APAC clinical nutrition market significantly, as the need for nutritional management continues to rise, particularly among youngsters and the elderly.
This research report on the APAC clinical nutrition market has been segmented and sub-segmented into the following categories:
By Product Type:
By Therapeutic Areas:
By Ingredients Type:
Geographically, in the Asia Pacific, China and India are expected to emerge fast in the forecast period due to the rise in population in the following countries.
India is the largest and fastest-growing market in the Asia Pacific region. According to a UNICEF report, 69% of deaths of children are caused by malnutrition in India. This country has initiated numerous awareness campaigns to increase people’s knowledge levels over clinical nutrition. For Instance, The Indian Association of Parental & Enteral Nutrition organization promotes clinical research, advanced education, and clinical quality and care control. The organization mainly focuses on improvement in the nutritional care of people at the stage of malnutrition or health-related diseases. Clinical Nutritionists create effective plans aimed at the nourishment of the body, strengthening of the immune system.
China is the second-largest market in the Asia Pacific clinical nutritional market and the most lucrative market. Increasing the economy partly responsible for growing parental nutrition coupled with excellent infrastructure and R &D facilities facilitates the Chinese clinical nutrition market during the forecast period.
The total population of Japan was calculated at 126.0 million in 2019. The National Nutrition Survey in Japan happens every year, and this survey aims to provide information on the food and nutrition intake of the Japanese people. In Japan, Clinical nutrition and related diet are considered an essential part of the lifestyle, which is estimated to favor the market in this country.
KEY MARKET PLAYERS:
A few of the promising companies operating in the APAC Clinical Nutrition Market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com